Global Multiplex Biomarker Imaging

Multiplex Biomarker Imaging Comprehensive Study by Type (Immunohistochemistry (IHC) Assay, Fluorescent In Situ, Hybridization (FISH) Assay, Tissue Microarray (TMA) Assay), Application (Oncology Studies, Drug Safety, Genetic Characterization, Others), Components (Kits, Instruments, Software, Other), End User (Research Institutes, Translational Lab, Pharma & Biopharma Companies, Hospitals, Others) Players and Region - Global Market Outlook to 2030

Multiplex Biomarker Imaging Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 11.9%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Multiplex Biomarker Imaging
Multiplex Biomarker Imaging is used to extract more and accurate information about the diseased tissues. Multiplexed staining approaches are expected to increase the amount of information that can be obtained from intact tumor anatomy as well as to delineate the spatial and temporal expression information. Multiplexed biomarker imaging can help expose the spatial associations between stromal and immune cells within tumors, allowing for more detailed characterization. Due to multiplexed biomarkers, with just tiny sample material, researchers can get detailed information quickly.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
CAGR11.9%


Analyst at AMA Research estimates that united States Players will contribute the maximum growth to Global Multiplex Biomarker Imaging market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Bio-Rad Laboratories, Inc. (United States), Ultivue Inc. (United States), Luminex Corporation (United States), Merck KGaA (Germany), BioTek Instruments, Inc (United States), Akoya Biosciences (United States), BioreclamationIVT. ELEVATING SCIENCE (United States) and Applied Micro Arrays (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Pacific Biomarkers (United States) and PerkinElmer Inc (United States).

Segmentation Overview
AMA Research has segmented the market of Global Multiplex Biomarker Imaging market by Type (Immunohistochemistry (IHC) Assay, Fluorescent In Situ, Hybridization (FISH) Assay and Tissue Microarray (TMA) Assay), Application (Oncology Studies, Drug Safety, Genetic Characterization and Others) and Region.



On the basis of geography, the market of Multiplex Biomarker Imaging has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Components, the sub-segment i.e. Kits will boost the Multiplex Biomarker Imaging market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Research Institutes will boost the Multiplex Biomarker Imaging market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Growing Research in The Multiplex Biomarker Imaging for More Accurate and Rapid Results

Market Growth Drivers:
Need of Rapid Precision Profiling in Tumour Biology and Need to Visualize Multiple Biomarkers

Challenges:
High Cost Associated with Multiplex Biomarker Imaging

Restraints:
Complex Nature of Biomarker Validation Hindering Multiplex Biomarker Imaging

Opportunities:
Increasing Investment in Cancer Treatment Will Boost the Demand of Multiplex Biomarker Imaging and Rapid Commercialization of Multiplex Biomarker Imaging Technology Will Increase Its Demand

Market Leaders and their expansionary development strategies
In April 2020, Bio-Rad Laboratories, Inc., leader of life science research and clinical diagnostic products, announced that it has acquired Celsee, Inc., a company that offers instruments and consumables for the isolation, detection, and analysis of single cells. Terms of the acquisition were not disclosed. Bio-Rad will discuss the acquisition in more detail during its first-quarter 2020 financial results conference call.
In November 2017, Ultivue announced the commercial launch of InSituPlex Services, which provides transformative tissue interrogation of protein biomarker expression patterns. The service is based on the company's patented InSituPlex technology, which allows for impartial biomarker analysis in tissue at the high multiplex and spatial resolution.


Key Target Audience
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Multiplex Biomarker Imaging Providers, Suppliers and Distributors, Government Regulatory and Research Organizations, End-Use Industries and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Immunohistochemistry (IHC) Assay
  • Fluorescent In Situ
  • Hybridization (FISH) Assay
  • Tissue Microarray (TMA) Assay
By Application
  • Oncology Studies
  • Drug Safety
  • Genetic Characterization
  • Others
By Components
  • Kits
  • Instruments
  • Software
  • Other

By End User
  • Research Institutes
  • Translational Lab
  • Pharma & Biopharma Companies
  • Hospitals
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Need of Rapid Precision Profiling in Tumour Biology
      • 3.2.2. Need to Visualize Multiple Biomarkers
    • 3.3. Market Challenges
      • 3.3.1. High Cost Associated with Multiplex Biomarker Imaging
    • 3.4. Market Trends
      • 3.4.1. Growing Research in The Multiplex Biomarker Imaging for More Accurate and Rapid Results
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Multiplex Biomarker Imaging, by Type, Application, Components, End User and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Multiplex Biomarker Imaging (Value)
      • 5.2.1. Global Multiplex Biomarker Imaging by: Type (Value)
        • 5.2.1.1. Immunohistochemistry (IHC) Assay
        • 5.2.1.2. Fluorescent In Situ
        • 5.2.1.3. Hybridization (FISH) Assay
        • 5.2.1.4. Tissue Microarray (TMA) Assay
      • 5.2.2. Global Multiplex Biomarker Imaging by: Application (Value)
        • 5.2.2.1. Oncology Studies
        • 5.2.2.2. Drug Safety
        • 5.2.2.3. Genetic Characterization
        • 5.2.2.4. Others
      • 5.2.3. Global Multiplex Biomarker Imaging by: Components (Value)
        • 5.2.3.1. Kits
        • 5.2.3.2. Instruments
        • 5.2.3.3. Software
        • 5.2.3.4. Other
      • 5.2.4. Global Multiplex Biomarker Imaging by: End User (Value)
        • 5.2.4.1. Research Institutes
        • 5.2.4.2. Translational Lab
        • 5.2.4.3. Pharma & Biopharma Companies
        • 5.2.4.4. Hospitals
        • 5.2.4.5. Others
      • 5.2.5. Global Multiplex Biomarker Imaging Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Multiplex Biomarker Imaging: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Bio-Rad Laboratories, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Ultivue Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Luminex Corporation (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Merck KGaA (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. BioTek Instruments, Inc (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Akoya Biosciences (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. BioreclamationIVT. ELEVATING SCIENCE (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Applied Micro Arrays (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Multiplex Biomarker Imaging Sale, by Type, Application, Components, End User and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Multiplex Biomarker Imaging (Value)
      • 7.2.1. Global Multiplex Biomarker Imaging by: Type (Value)
        • 7.2.1.1. Immunohistochemistry (IHC) Assay
        • 7.2.1.2. Fluorescent In Situ
        • 7.2.1.3. Hybridization (FISH) Assay
        • 7.2.1.4. Tissue Microarray (TMA) Assay
      • 7.2.2. Global Multiplex Biomarker Imaging by: Application (Value)
        • 7.2.2.1. Oncology Studies
        • 7.2.2.2. Drug Safety
        • 7.2.2.3. Genetic Characterization
        • 7.2.2.4. Others
      • 7.2.3. Global Multiplex Biomarker Imaging by: Components (Value)
        • 7.2.3.1. Kits
        • 7.2.3.2. Instruments
        • 7.2.3.3. Software
        • 7.2.3.4. Other
      • 7.2.4. Global Multiplex Biomarker Imaging by: End User (Value)
        • 7.2.4.1. Research Institutes
        • 7.2.4.2. Translational Lab
        • 7.2.4.3. Pharma & Biopharma Companies
        • 7.2.4.4. Hospitals
        • 7.2.4.5. Others
      • 7.2.5. Global Multiplex Biomarker Imaging Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Multiplex Biomarker Imaging: by Type(USD Million)
  • Table 2. Multiplex Biomarker Imaging Immunohistochemistry (IHC) Assay , by Region USD Million (2018-2023)
  • Table 3. Multiplex Biomarker Imaging Fluorescent In Situ , by Region USD Million (2018-2023)
  • Table 4. Multiplex Biomarker Imaging Hybridization (FISH) Assay , by Region USD Million (2018-2023)
  • Table 5. Multiplex Biomarker Imaging Tissue Microarray (TMA) Assay , by Region USD Million (2018-2023)
  • Table 6. Multiplex Biomarker Imaging: by Application(USD Million)
  • Table 7. Multiplex Biomarker Imaging Oncology Studies , by Region USD Million (2018-2023)
  • Table 8. Multiplex Biomarker Imaging Drug Safety , by Region USD Million (2018-2023)
  • Table 9. Multiplex Biomarker Imaging Genetic Characterization , by Region USD Million (2018-2023)
  • Table 10. Multiplex Biomarker Imaging Others , by Region USD Million (2018-2023)
  • Table 11. Multiplex Biomarker Imaging: by Components(USD Million)
  • Table 12. Multiplex Biomarker Imaging Kits , by Region USD Million (2018-2023)
  • Table 13. Multiplex Biomarker Imaging Instruments , by Region USD Million (2018-2023)
  • Table 14. Multiplex Biomarker Imaging Software , by Region USD Million (2018-2023)
  • Table 15. Multiplex Biomarker Imaging Other , by Region USD Million (2018-2023)
  • Table 16. Multiplex Biomarker Imaging: by End User(USD Million)
  • Table 17. Multiplex Biomarker Imaging Research Institutes , by Region USD Million (2018-2023)
  • Table 18. Multiplex Biomarker Imaging Translational Lab , by Region USD Million (2018-2023)
  • Table 19. Multiplex Biomarker Imaging Pharma & Biopharma Companies , by Region USD Million (2018-2023)
  • Table 20. Multiplex Biomarker Imaging Hospitals , by Region USD Million (2018-2023)
  • Table 21. Multiplex Biomarker Imaging Others , by Region USD Million (2018-2023)
  • Table 22. South America Multiplex Biomarker Imaging, by Country USD Million (2018-2023)
  • Table 23. South America Multiplex Biomarker Imaging, by Type USD Million (2018-2023)
  • Table 24. South America Multiplex Biomarker Imaging, by Application USD Million (2018-2023)
  • Table 25. South America Multiplex Biomarker Imaging, by Components USD Million (2018-2023)
  • Table 26. South America Multiplex Biomarker Imaging, by End User USD Million (2018-2023)
  • Table 27. Brazil Multiplex Biomarker Imaging, by Type USD Million (2018-2023)
  • Table 28. Brazil Multiplex Biomarker Imaging, by Application USD Million (2018-2023)
  • Table 29. Brazil Multiplex Biomarker Imaging, by Components USD Million (2018-2023)
  • Table 30. Brazil Multiplex Biomarker Imaging, by End User USD Million (2018-2023)
  • Table 31. Argentina Multiplex Biomarker Imaging, by Type USD Million (2018-2023)
  • Table 32. Argentina Multiplex Biomarker Imaging, by Application USD Million (2018-2023)
  • Table 33. Argentina Multiplex Biomarker Imaging, by Components USD Million (2018-2023)
  • Table 34. Argentina Multiplex Biomarker Imaging, by End User USD Million (2018-2023)
  • Table 35. Rest of South America Multiplex Biomarker Imaging, by Type USD Million (2018-2023)
  • Table 36. Rest of South America Multiplex Biomarker Imaging, by Application USD Million (2018-2023)
  • Table 37. Rest of South America Multiplex Biomarker Imaging, by Components USD Million (2018-2023)
  • Table 38. Rest of South America Multiplex Biomarker Imaging, by End User USD Million (2018-2023)
  • Table 39. Asia Pacific Multiplex Biomarker Imaging, by Country USD Million (2018-2023)
  • Table 40. Asia Pacific Multiplex Biomarker Imaging, by Type USD Million (2018-2023)
  • Table 41. Asia Pacific Multiplex Biomarker Imaging, by Application USD Million (2018-2023)
  • Table 42. Asia Pacific Multiplex Biomarker Imaging, by Components USD Million (2018-2023)
  • Table 43. Asia Pacific Multiplex Biomarker Imaging, by End User USD Million (2018-2023)
  • Table 44. China Multiplex Biomarker Imaging, by Type USD Million (2018-2023)
  • Table 45. China Multiplex Biomarker Imaging, by Application USD Million (2018-2023)
  • Table 46. China Multiplex Biomarker Imaging, by Components USD Million (2018-2023)
  • Table 47. China Multiplex Biomarker Imaging, by End User USD Million (2018-2023)
  • Table 48. Japan Multiplex Biomarker Imaging, by Type USD Million (2018-2023)
  • Table 49. Japan Multiplex Biomarker Imaging, by Application USD Million (2018-2023)
  • Table 50. Japan Multiplex Biomarker Imaging, by Components USD Million (2018-2023)
  • Table 51. Japan Multiplex Biomarker Imaging, by End User USD Million (2018-2023)
  • Table 52. India Multiplex Biomarker Imaging, by Type USD Million (2018-2023)
  • Table 53. India Multiplex Biomarker Imaging, by Application USD Million (2018-2023)
  • Table 54. India Multiplex Biomarker Imaging, by Components USD Million (2018-2023)
  • Table 55. India Multiplex Biomarker Imaging, by End User USD Million (2018-2023)
  • Table 56. South Korea Multiplex Biomarker Imaging, by Type USD Million (2018-2023)
  • Table 57. South Korea Multiplex Biomarker Imaging, by Application USD Million (2018-2023)
  • Table 58. South Korea Multiplex Biomarker Imaging, by Components USD Million (2018-2023)
  • Table 59. South Korea Multiplex Biomarker Imaging, by End User USD Million (2018-2023)
  • Table 60. Taiwan Multiplex Biomarker Imaging, by Type USD Million (2018-2023)
  • Table 61. Taiwan Multiplex Biomarker Imaging, by Application USD Million (2018-2023)
  • Table 62. Taiwan Multiplex Biomarker Imaging, by Components USD Million (2018-2023)
  • Table 63. Taiwan Multiplex Biomarker Imaging, by End User USD Million (2018-2023)
  • Table 64. Australia Multiplex Biomarker Imaging, by Type USD Million (2018-2023)
  • Table 65. Australia Multiplex Biomarker Imaging, by Application USD Million (2018-2023)
  • Table 66. Australia Multiplex Biomarker Imaging, by Components USD Million (2018-2023)
  • Table 67. Australia Multiplex Biomarker Imaging, by End User USD Million (2018-2023)
  • Table 68. Rest of Asia-Pacific Multiplex Biomarker Imaging, by Type USD Million (2018-2023)
  • Table 69. Rest of Asia-Pacific Multiplex Biomarker Imaging, by Application USD Million (2018-2023)
  • Table 70. Rest of Asia-Pacific Multiplex Biomarker Imaging, by Components USD Million (2018-2023)
  • Table 71. Rest of Asia-Pacific Multiplex Biomarker Imaging, by End User USD Million (2018-2023)
  • Table 72. Europe Multiplex Biomarker Imaging, by Country USD Million (2018-2023)
  • Table 73. Europe Multiplex Biomarker Imaging, by Type USD Million (2018-2023)
  • Table 74. Europe Multiplex Biomarker Imaging, by Application USD Million (2018-2023)
  • Table 75. Europe Multiplex Biomarker Imaging, by Components USD Million (2018-2023)
  • Table 76. Europe Multiplex Biomarker Imaging, by End User USD Million (2018-2023)
  • Table 77. Germany Multiplex Biomarker Imaging, by Type USD Million (2018-2023)
  • Table 78. Germany Multiplex Biomarker Imaging, by Application USD Million (2018-2023)
  • Table 79. Germany Multiplex Biomarker Imaging, by Components USD Million (2018-2023)
  • Table 80. Germany Multiplex Biomarker Imaging, by End User USD Million (2018-2023)
  • Table 81. France Multiplex Biomarker Imaging, by Type USD Million (2018-2023)
  • Table 82. France Multiplex Biomarker Imaging, by Application USD Million (2018-2023)
  • Table 83. France Multiplex Biomarker Imaging, by Components USD Million (2018-2023)
  • Table 84. France Multiplex Biomarker Imaging, by End User USD Million (2018-2023)
  • Table 85. Italy Multiplex Biomarker Imaging, by Type USD Million (2018-2023)
  • Table 86. Italy Multiplex Biomarker Imaging, by Application USD Million (2018-2023)
  • Table 87. Italy Multiplex Biomarker Imaging, by Components USD Million (2018-2023)
  • Table 88. Italy Multiplex Biomarker Imaging, by End User USD Million (2018-2023)
  • Table 89. United Kingdom Multiplex Biomarker Imaging, by Type USD Million (2018-2023)
  • Table 90. United Kingdom Multiplex Biomarker Imaging, by Application USD Million (2018-2023)
  • Table 91. United Kingdom Multiplex Biomarker Imaging, by Components USD Million (2018-2023)
  • Table 92. United Kingdom Multiplex Biomarker Imaging, by End User USD Million (2018-2023)
  • Table 93. Netherlands Multiplex Biomarker Imaging, by Type USD Million (2018-2023)
  • Table 94. Netherlands Multiplex Biomarker Imaging, by Application USD Million (2018-2023)
  • Table 95. Netherlands Multiplex Biomarker Imaging, by Components USD Million (2018-2023)
  • Table 96. Netherlands Multiplex Biomarker Imaging, by End User USD Million (2018-2023)
  • Table 97. Rest of Europe Multiplex Biomarker Imaging, by Type USD Million (2018-2023)
  • Table 98. Rest of Europe Multiplex Biomarker Imaging, by Application USD Million (2018-2023)
  • Table 99. Rest of Europe Multiplex Biomarker Imaging, by Components USD Million (2018-2023)
  • Table 100. Rest of Europe Multiplex Biomarker Imaging, by End User USD Million (2018-2023)
  • Table 101. MEA Multiplex Biomarker Imaging, by Country USD Million (2018-2023)
  • Table 102. MEA Multiplex Biomarker Imaging, by Type USD Million (2018-2023)
  • Table 103. MEA Multiplex Biomarker Imaging, by Application USD Million (2018-2023)
  • Table 104. MEA Multiplex Biomarker Imaging, by Components USD Million (2018-2023)
  • Table 105. MEA Multiplex Biomarker Imaging, by End User USD Million (2018-2023)
  • Table 106. Middle East Multiplex Biomarker Imaging, by Type USD Million (2018-2023)
  • Table 107. Middle East Multiplex Biomarker Imaging, by Application USD Million (2018-2023)
  • Table 108. Middle East Multiplex Biomarker Imaging, by Components USD Million (2018-2023)
  • Table 109. Middle East Multiplex Biomarker Imaging, by End User USD Million (2018-2023)
  • Table 110. Africa Multiplex Biomarker Imaging, by Type USD Million (2018-2023)
  • Table 111. Africa Multiplex Biomarker Imaging, by Application USD Million (2018-2023)
  • Table 112. Africa Multiplex Biomarker Imaging, by Components USD Million (2018-2023)
  • Table 113. Africa Multiplex Biomarker Imaging, by End User USD Million (2018-2023)
  • Table 114. North America Multiplex Biomarker Imaging, by Country USD Million (2018-2023)
  • Table 115. North America Multiplex Biomarker Imaging, by Type USD Million (2018-2023)
  • Table 116. North America Multiplex Biomarker Imaging, by Application USD Million (2018-2023)
  • Table 117. North America Multiplex Biomarker Imaging, by Components USD Million (2018-2023)
  • Table 118. North America Multiplex Biomarker Imaging, by End User USD Million (2018-2023)
  • Table 119. United States Multiplex Biomarker Imaging, by Type USD Million (2018-2023)
  • Table 120. United States Multiplex Biomarker Imaging, by Application USD Million (2018-2023)
  • Table 121. United States Multiplex Biomarker Imaging, by Components USD Million (2018-2023)
  • Table 122. United States Multiplex Biomarker Imaging, by End User USD Million (2018-2023)
  • Table 123. Canada Multiplex Biomarker Imaging, by Type USD Million (2018-2023)
  • Table 124. Canada Multiplex Biomarker Imaging, by Application USD Million (2018-2023)
  • Table 125. Canada Multiplex Biomarker Imaging, by Components USD Million (2018-2023)
  • Table 126. Canada Multiplex Biomarker Imaging, by End User USD Million (2018-2023)
  • Table 127. Mexico Multiplex Biomarker Imaging, by Type USD Million (2018-2023)
  • Table 128. Mexico Multiplex Biomarker Imaging, by Application USD Million (2018-2023)
  • Table 129. Mexico Multiplex Biomarker Imaging, by Components USD Million (2018-2023)
  • Table 130. Mexico Multiplex Biomarker Imaging, by End User USD Million (2018-2023)
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Multiplex Biomarker Imaging: by Type(USD Million)
  • Table 140. Multiplex Biomarker Imaging Immunohistochemistry (IHC) Assay , by Region USD Million (2025-2030)
  • Table 141. Multiplex Biomarker Imaging Fluorescent In Situ , by Region USD Million (2025-2030)
  • Table 142. Multiplex Biomarker Imaging Hybridization (FISH) Assay , by Region USD Million (2025-2030)
  • Table 143. Multiplex Biomarker Imaging Tissue Microarray (TMA) Assay , by Region USD Million (2025-2030)
  • Table 144. Multiplex Biomarker Imaging: by Application(USD Million)
  • Table 145. Multiplex Biomarker Imaging Oncology Studies , by Region USD Million (2025-2030)
  • Table 146. Multiplex Biomarker Imaging Drug Safety , by Region USD Million (2025-2030)
  • Table 147. Multiplex Biomarker Imaging Genetic Characterization , by Region USD Million (2025-2030)
  • Table 148. Multiplex Biomarker Imaging Others , by Region USD Million (2025-2030)
  • Table 149. Multiplex Biomarker Imaging: by Components(USD Million)
  • Table 150. Multiplex Biomarker Imaging Kits , by Region USD Million (2025-2030)
  • Table 151. Multiplex Biomarker Imaging Instruments , by Region USD Million (2025-2030)
  • Table 152. Multiplex Biomarker Imaging Software , by Region USD Million (2025-2030)
  • Table 153. Multiplex Biomarker Imaging Other , by Region USD Million (2025-2030)
  • Table 154. Multiplex Biomarker Imaging: by End User(USD Million)
  • Table 155. Multiplex Biomarker Imaging Research Institutes , by Region USD Million (2025-2030)
  • Table 156. Multiplex Biomarker Imaging Translational Lab , by Region USD Million (2025-2030)
  • Table 157. Multiplex Biomarker Imaging Pharma & Biopharma Companies , by Region USD Million (2025-2030)
  • Table 158. Multiplex Biomarker Imaging Hospitals , by Region USD Million (2025-2030)
  • Table 159. Multiplex Biomarker Imaging Others , by Region USD Million (2025-2030)
  • Table 160. South America Multiplex Biomarker Imaging, by Country USD Million (2025-2030)
  • Table 161. South America Multiplex Biomarker Imaging, by Type USD Million (2025-2030)
  • Table 162. South America Multiplex Biomarker Imaging, by Application USD Million (2025-2030)
  • Table 163. South America Multiplex Biomarker Imaging, by Components USD Million (2025-2030)
  • Table 164. South America Multiplex Biomarker Imaging, by End User USD Million (2025-2030)
  • Table 165. Brazil Multiplex Biomarker Imaging, by Type USD Million (2025-2030)
  • Table 166. Brazil Multiplex Biomarker Imaging, by Application USD Million (2025-2030)
  • Table 167. Brazil Multiplex Biomarker Imaging, by Components USD Million (2025-2030)
  • Table 168. Brazil Multiplex Biomarker Imaging, by End User USD Million (2025-2030)
  • Table 169. Argentina Multiplex Biomarker Imaging, by Type USD Million (2025-2030)
  • Table 170. Argentina Multiplex Biomarker Imaging, by Application USD Million (2025-2030)
  • Table 171. Argentina Multiplex Biomarker Imaging, by Components USD Million (2025-2030)
  • Table 172. Argentina Multiplex Biomarker Imaging, by End User USD Million (2025-2030)
  • Table 173. Rest of South America Multiplex Biomarker Imaging, by Type USD Million (2025-2030)
  • Table 174. Rest of South America Multiplex Biomarker Imaging, by Application USD Million (2025-2030)
  • Table 175. Rest of South America Multiplex Biomarker Imaging, by Components USD Million (2025-2030)
  • Table 176. Rest of South America Multiplex Biomarker Imaging, by End User USD Million (2025-2030)
  • Table 177. Asia Pacific Multiplex Biomarker Imaging, by Country USD Million (2025-2030)
  • Table 178. Asia Pacific Multiplex Biomarker Imaging, by Type USD Million (2025-2030)
  • Table 179. Asia Pacific Multiplex Biomarker Imaging, by Application USD Million (2025-2030)
  • Table 180. Asia Pacific Multiplex Biomarker Imaging, by Components USD Million (2025-2030)
  • Table 181. Asia Pacific Multiplex Biomarker Imaging, by End User USD Million (2025-2030)
  • Table 182. China Multiplex Biomarker Imaging, by Type USD Million (2025-2030)
  • Table 183. China Multiplex Biomarker Imaging, by Application USD Million (2025-2030)
  • Table 184. China Multiplex Biomarker Imaging, by Components USD Million (2025-2030)
  • Table 185. China Multiplex Biomarker Imaging, by End User USD Million (2025-2030)
  • Table 186. Japan Multiplex Biomarker Imaging, by Type USD Million (2025-2030)
  • Table 187. Japan Multiplex Biomarker Imaging, by Application USD Million (2025-2030)
  • Table 188. Japan Multiplex Biomarker Imaging, by Components USD Million (2025-2030)
  • Table 189. Japan Multiplex Biomarker Imaging, by End User USD Million (2025-2030)
  • Table 190. India Multiplex Biomarker Imaging, by Type USD Million (2025-2030)
  • Table 191. India Multiplex Biomarker Imaging, by Application USD Million (2025-2030)
  • Table 192. India Multiplex Biomarker Imaging, by Components USD Million (2025-2030)
  • Table 193. India Multiplex Biomarker Imaging, by End User USD Million (2025-2030)
  • Table 194. South Korea Multiplex Biomarker Imaging, by Type USD Million (2025-2030)
  • Table 195. South Korea Multiplex Biomarker Imaging, by Application USD Million (2025-2030)
  • Table 196. South Korea Multiplex Biomarker Imaging, by Components USD Million (2025-2030)
  • Table 197. South Korea Multiplex Biomarker Imaging, by End User USD Million (2025-2030)
  • Table 198. Taiwan Multiplex Biomarker Imaging, by Type USD Million (2025-2030)
  • Table 199. Taiwan Multiplex Biomarker Imaging, by Application USD Million (2025-2030)
  • Table 200. Taiwan Multiplex Biomarker Imaging, by Components USD Million (2025-2030)
  • Table 201. Taiwan Multiplex Biomarker Imaging, by End User USD Million (2025-2030)
  • Table 202. Australia Multiplex Biomarker Imaging, by Type USD Million (2025-2030)
  • Table 203. Australia Multiplex Biomarker Imaging, by Application USD Million (2025-2030)
  • Table 204. Australia Multiplex Biomarker Imaging, by Components USD Million (2025-2030)
  • Table 205. Australia Multiplex Biomarker Imaging, by End User USD Million (2025-2030)
  • Table 206. Rest of Asia-Pacific Multiplex Biomarker Imaging, by Type USD Million (2025-2030)
  • Table 207. Rest of Asia-Pacific Multiplex Biomarker Imaging, by Application USD Million (2025-2030)
  • Table 208. Rest of Asia-Pacific Multiplex Biomarker Imaging, by Components USD Million (2025-2030)
  • Table 209. Rest of Asia-Pacific Multiplex Biomarker Imaging, by End User USD Million (2025-2030)
  • Table 210. Europe Multiplex Biomarker Imaging, by Country USD Million (2025-2030)
  • Table 211. Europe Multiplex Biomarker Imaging, by Type USD Million (2025-2030)
  • Table 212. Europe Multiplex Biomarker Imaging, by Application USD Million (2025-2030)
  • Table 213. Europe Multiplex Biomarker Imaging, by Components USD Million (2025-2030)
  • Table 214. Europe Multiplex Biomarker Imaging, by End User USD Million (2025-2030)
  • Table 215. Germany Multiplex Biomarker Imaging, by Type USD Million (2025-2030)
  • Table 216. Germany Multiplex Biomarker Imaging, by Application USD Million (2025-2030)
  • Table 217. Germany Multiplex Biomarker Imaging, by Components USD Million (2025-2030)
  • Table 218. Germany Multiplex Biomarker Imaging, by End User USD Million (2025-2030)
  • Table 219. France Multiplex Biomarker Imaging, by Type USD Million (2025-2030)
  • Table 220. France Multiplex Biomarker Imaging, by Application USD Million (2025-2030)
  • Table 221. France Multiplex Biomarker Imaging, by Components USD Million (2025-2030)
  • Table 222. France Multiplex Biomarker Imaging, by End User USD Million (2025-2030)
  • Table 223. Italy Multiplex Biomarker Imaging, by Type USD Million (2025-2030)
  • Table 224. Italy Multiplex Biomarker Imaging, by Application USD Million (2025-2030)
  • Table 225. Italy Multiplex Biomarker Imaging, by Components USD Million (2025-2030)
  • Table 226. Italy Multiplex Biomarker Imaging, by End User USD Million (2025-2030)
  • Table 227. United Kingdom Multiplex Biomarker Imaging, by Type USD Million (2025-2030)
  • Table 228. United Kingdom Multiplex Biomarker Imaging, by Application USD Million (2025-2030)
  • Table 229. United Kingdom Multiplex Biomarker Imaging, by Components USD Million (2025-2030)
  • Table 230. United Kingdom Multiplex Biomarker Imaging, by End User USD Million (2025-2030)
  • Table 231. Netherlands Multiplex Biomarker Imaging, by Type USD Million (2025-2030)
  • Table 232. Netherlands Multiplex Biomarker Imaging, by Application USD Million (2025-2030)
  • Table 233. Netherlands Multiplex Biomarker Imaging, by Components USD Million (2025-2030)
  • Table 234. Netherlands Multiplex Biomarker Imaging, by End User USD Million (2025-2030)
  • Table 235. Rest of Europe Multiplex Biomarker Imaging, by Type USD Million (2025-2030)
  • Table 236. Rest of Europe Multiplex Biomarker Imaging, by Application USD Million (2025-2030)
  • Table 237. Rest of Europe Multiplex Biomarker Imaging, by Components USD Million (2025-2030)
  • Table 238. Rest of Europe Multiplex Biomarker Imaging, by End User USD Million (2025-2030)
  • Table 239. MEA Multiplex Biomarker Imaging, by Country USD Million (2025-2030)
  • Table 240. MEA Multiplex Biomarker Imaging, by Type USD Million (2025-2030)
  • Table 241. MEA Multiplex Biomarker Imaging, by Application USD Million (2025-2030)
  • Table 242. MEA Multiplex Biomarker Imaging, by Components USD Million (2025-2030)
  • Table 243. MEA Multiplex Biomarker Imaging, by End User USD Million (2025-2030)
  • Table 244. Middle East Multiplex Biomarker Imaging, by Type USD Million (2025-2030)
  • Table 245. Middle East Multiplex Biomarker Imaging, by Application USD Million (2025-2030)
  • Table 246. Middle East Multiplex Biomarker Imaging, by Components USD Million (2025-2030)
  • Table 247. Middle East Multiplex Biomarker Imaging, by End User USD Million (2025-2030)
  • Table 248. Africa Multiplex Biomarker Imaging, by Type USD Million (2025-2030)
  • Table 249. Africa Multiplex Biomarker Imaging, by Application USD Million (2025-2030)
  • Table 250. Africa Multiplex Biomarker Imaging, by Components USD Million (2025-2030)
  • Table 251. Africa Multiplex Biomarker Imaging, by End User USD Million (2025-2030)
  • Table 252. North America Multiplex Biomarker Imaging, by Country USD Million (2025-2030)
  • Table 253. North America Multiplex Biomarker Imaging, by Type USD Million (2025-2030)
  • Table 254. North America Multiplex Biomarker Imaging, by Application USD Million (2025-2030)
  • Table 255. North America Multiplex Biomarker Imaging, by Components USD Million (2025-2030)
  • Table 256. North America Multiplex Biomarker Imaging, by End User USD Million (2025-2030)
  • Table 257. United States Multiplex Biomarker Imaging, by Type USD Million (2025-2030)
  • Table 258. United States Multiplex Biomarker Imaging, by Application USD Million (2025-2030)
  • Table 259. United States Multiplex Biomarker Imaging, by Components USD Million (2025-2030)
  • Table 260. United States Multiplex Biomarker Imaging, by End User USD Million (2025-2030)
  • Table 261. Canada Multiplex Biomarker Imaging, by Type USD Million (2025-2030)
  • Table 262. Canada Multiplex Biomarker Imaging, by Application USD Million (2025-2030)
  • Table 263. Canada Multiplex Biomarker Imaging, by Components USD Million (2025-2030)
  • Table 264. Canada Multiplex Biomarker Imaging, by End User USD Million (2025-2030)
  • Table 265. Mexico Multiplex Biomarker Imaging, by Type USD Million (2025-2030)
  • Table 266. Mexico Multiplex Biomarker Imaging, by Application USD Million (2025-2030)
  • Table 267. Mexico Multiplex Biomarker Imaging, by Components USD Million (2025-2030)
  • Table 268. Mexico Multiplex Biomarker Imaging, by End User USD Million (2025-2030)
  • Table 269. Research Programs/Design for This Report
  • Table 270. Key Data Information from Secondary Sources
  • Table 271. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Multiplex Biomarker Imaging: by Type USD Million (2018-2023)
  • Figure 5. Global Multiplex Biomarker Imaging: by Application USD Million (2018-2023)
  • Figure 6. Global Multiplex Biomarker Imaging: by Components USD Million (2018-2023)
  • Figure 7. Global Multiplex Biomarker Imaging: by End User USD Million (2018-2023)
  • Figure 8. South America Multiplex Biomarker Imaging Share (%), by Country
  • Figure 9. Asia Pacific Multiplex Biomarker Imaging Share (%), by Country
  • Figure 10. Europe Multiplex Biomarker Imaging Share (%), by Country
  • Figure 11. MEA Multiplex Biomarker Imaging Share (%), by Country
  • Figure 12. North America Multiplex Biomarker Imaging Share (%), by Country
  • Figure 13. Global Multiplex Biomarker Imaging share by Players 2023 (%)
  • Figure 14. Global Multiplex Biomarker Imaging share by Players (Top 3) 2023(%)
  • Figure 15. Global Multiplex Biomarker Imaging share by Players (Top 5) 2023(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Bio-Rad Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 18. Bio-Rad Laboratories, Inc. (United States) Revenue: by Geography 2023
  • Figure 19. Ultivue Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. Ultivue Inc. (United States) Revenue: by Geography 2023
  • Figure 21. Luminex Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 22. Luminex Corporation (United States) Revenue: by Geography 2023
  • Figure 23. Merck KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 24. Merck KGaA (Germany) Revenue: by Geography 2023
  • Figure 25. BioTek Instruments, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 26. BioTek Instruments, Inc (United States) Revenue: by Geography 2023
  • Figure 27. Akoya Biosciences (United States) Revenue, Net Income and Gross profit
  • Figure 28. Akoya Biosciences (United States) Revenue: by Geography 2023
  • Figure 29. BioreclamationIVT. ELEVATING SCIENCE (United States) Revenue, Net Income and Gross profit
  • Figure 30. BioreclamationIVT. ELEVATING SCIENCE (United States) Revenue: by Geography 2023
  • Figure 31. Applied Micro Arrays (United States) Revenue, Net Income and Gross profit
  • Figure 32. Applied Micro Arrays (United States) Revenue: by Geography 2023
  • Figure 33. Global Multiplex Biomarker Imaging: by Type USD Million (2025-2030)
  • Figure 34. Global Multiplex Biomarker Imaging: by Application USD Million (2025-2030)
  • Figure 35. Global Multiplex Biomarker Imaging: by Components USD Million (2025-2030)
  • Figure 36. Global Multiplex Biomarker Imaging: by End User USD Million (2025-2030)
  • Figure 37. South America Multiplex Biomarker Imaging Share (%), by Country
  • Figure 38. Asia Pacific Multiplex Biomarker Imaging Share (%), by Country
  • Figure 39. Europe Multiplex Biomarker Imaging Share (%), by Country
  • Figure 40. MEA Multiplex Biomarker Imaging Share (%), by Country
  • Figure 41. North America Multiplex Biomarker Imaging Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Bio-Rad Laboratories, Inc. (United States)
  • Ultivue Inc. (United States)
  • Luminex Corporation (United States)
  • Merck KGaA (Germany)
  • BioTek Instruments, Inc (United States)
  • Akoya Biosciences (United States)
  • BioreclamationIVT. ELEVATING SCIENCE (United States)
  • Applied Micro Arrays (United States)
Additional players considered in the study are as follows:
Pacific Biomarkers (United States) , PerkinElmer Inc (United States)
Select User Access Type

Key Highlights of Report


Apr 2024 232 Pages 69 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Multiplex Biomarker Imaging Quantitative research analysis
Global Multiplex Biomarker Imaging Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Bio-Rad Laboratories, Inc. (United States), Ultivue Inc. (United States), Luminex Corporation (United States), Merck KGaA (Germany), BioTek Instruments, Inc (United States), Akoya Biosciences (United States), BioreclamationIVT. ELEVATING SCIENCE (United States) and Applied Micro Arrays (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Growing Research in The Multiplex Biomarker Imaging for More Accurate and Rapid Results" is seen as one of major influencing trends for Multiplex Biomarker Imaging Market during projected period 2023-2030.
The Multiplex Biomarker Imaging market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Multiplex Biomarker Imaging Report?

Have a Query? Click Here

Other Related Reports

Food Irradiation Comprehensive Study by Food type (Fruits and Vegetables, Spices, Grain Foods, Meat and Poultry), Sources or radiation (Gamma rays, X rays, Electron beam), Dose (High, Low) Players an...
$ 3500
Anatomical models Comprehensive Study by Type (Skeleton & Muscular Models, Dental Models, Head & Skull & Nervous Models, Torso & Organ Models, Veterinary Models), Application (Hospitals, Scientific R...
$ 3650
LCD Digital Microscope Comprehensive Study by Type (Stationary, Portable), Application (Basic Research, Biopharmaceutical Production, Drug Discovery and Development, Forensic Testing, Tissue Engineer...
$ 3750
Biologics and Biosimilars Comprehensive Study by Type (Monoclonal Antibodies, Interferon, Erythropoietin, Insulin, Vaccines, Other), Application (Tumor, Diabetes, Cardiovascular, Hemophilia, Other), ...
$ 3750
Test Tubes Comprehensive Study by Type (Disposable, Reusable), Application (Chemistry, Biosciences, Medical, Other), Capacity (3 ml, 5 ml, 9 ml, 14 ml, Others), Sales Channel (Online, Offline), Mater...
$ 3350
Life Science Tool Comprehensive Study by Type (Detection Probes , Light Microscopy , Confocal Microscopy , Electron Microscopy , Others ), Application (DNA Research , RNA Research , Proteomics , Prot...
$ 3350